Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment reporting

Analytics

Phase 3

1(33.3%)

Phase 4

1(33.3%)

Early Phase 1

1(33.3%)

3Total

Phase 3(1)

Phase 4(1)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05369884Early Phase 1Unknown

Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D

Role: collaborator

NCT02781285Unknown

Effect Study of Clinical Outcomes of Traditional Chinese Medicine to Advanced Gastric Cancer by Propensity Score

Role: collaborator

NCT02958020Recruiting

Multicenter Cohort Study on Osteoporosis

Role: collaborator

NCT03236636Phase 3Unknown

The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects

Role: collaborator

NCT03658291Phase 4Unknown

Clinical Study of Sanjin Tablets for the Treatment of Acute Simple Lower Urinary Tract Infection

Role: collaborator

NCT02094638Completed

Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study

Role: collaborator

All 6 trials loaded